User:Mr. Ibrahem/Beclometasone/formoterol

Beclometasone/formoterol, sold under the brand name Fostair, is a combination medication used to treat asthma and chronic obstructive pulmonary disease (COPD). In asthma it may be used both as long-term prevention and for sudden worsening. It is a second line treatment. It is used by breathing the medication in.

Side effects are those of the two medications it contains. These may include pneumonia, thrush, allergic reactions, low potassium, headache, glaucoma, and blurry vision. Safety in pregnancy is unclear. It contains beclometasone dipropionate, a corticosteroid; and formoterol fumarate dihydrate a long-acting β2 agonist (LABA).

The combination was approved for medical use in the United Kingdom in 2007, and Australia in 2020. It is on the World Health Organization's List of Essential Medicines as an alternative to budesonide/formoterol. In the United Kingdom 120 doses costs the NHS about £30 as of 2023.